ESEkapob Sangariyavanich

Ekapob Sangariyavanich

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ekapob Sangariyavanich has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Ammarin Thakkinstian

    Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

    1 shared publication
  • Boonyita Pakkaranang

    1 shared publication
  • Boonyita Pakkaranang

    Department of Digital Medical Working Group, National Cancer Institute, Bangkok, Thailand

    1 shared publication
  • Gareth J McKay

    Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland, UK

    1 shared publication
  • Nat Tangchitnob

    Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

    1 shared publication
  • Nawanan Theera-Ampornpunt

    Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

    1 shared publication

Latest Publications

  • Open Access

    Retrieval-augmented generation for BCLC staging classification using open-source large language models

    by Ekapob Sangariyavanich, Boonyita Pakkaranang, Sarat Sanguanlost, Nutchanun Preechakawin, Soros Anuchapreeda

  • Open Access

    Detection of cancer recurrence from Thai-English electronic medical records using sentence embeddings

    by Ekapob Sangariyavanich, Wanchana Ponthongmak, Nawanan Theera-Ampornpunt, Nat Tangchitnob, Gareth J McKay, Ammarin Thakkinstian

    Objective: This study developed and validated monolingual and bilingual sentence-bidirectional encoder representations from transformers (SBERT) models for detecting cancer recurrence within Thai-English electronic medical records (EMRs) from Thai cancer hospitals. Method: A multicentre dataset of 32 436 documents from 1250 patients was used for model development. External validation involved an independent dataset of 9244 documents from 384 patients across two Thai cancer hospitals. Performance was benchmarked against a fine-tuned PubMedBERT (MetBERT). Results: The development dataset included breast (43.9%), colorectal (12.1%), cervical (28.0%) and head and neck (16.0%) cancers. MetBERT achieved the highest area under the precision-recall curve (AUPRC) for locoregional versus no recurrence (11.1%) and locoregional versus distant recurrence (91.7%), while monolingual-SBERT excelled at distant versus no recurrence (32.0%). External validation demonstrated MetBERT superiority for locoregional versus no recurrence (9.30%–21.50%). For distant versus no recurrence, bilingual-SBERT performed best with AUPRC 17.55%–24.39%. While MetBERT led in distinguishing locoregional versus distant recurrence (88.30%–94.70%), bilingual-SBERT demonstrated robust external validation performance (AUPRC 85.25%–91.80%). Discussion: Low AUPRC values (9%–32%) reflect the extreme class imbalance in real-world data (~1% recurrence prevalence). Despite this, fine-tuned MetBERT achieved highest performance, while bilingual-SBERT demonstrated superior robustness during external validation. This validates sentence embedding models for handling mixed Thai-English medical records in multilingual clinical environments. Conclusion: Sentence embedding frameworks provide a practical, generalisable solution for detecting cancer recurrence within multilingual EMRs. Despite text-length constraints, these models are suitable for clinical integration as a screening tool for cancer registry workflows.

  • Open Access

    The situation of gynecological cancers in Thailand: incidence, histopathology, and survival outcomes from national cancer registry data

    by Supakorn Pitakkarnkul, Siriwan Tangjitgamol, Ekapob Sangariyavanich, Rangsiya Buasom, Boonyita Pakkaranang, Uraiwan Khomphaiboonkij, Warangkana Kolaka

    Pitakkarnkul S, et al. J Gynecol Oncol. 2025 Dec;37:e56. https://doi.org/10.3802/jgo.2026.37.e56